Investigating a new scanner to differentiate breast cancer from benign lesions
An Investigation Into Dielectric Assessment of Permittivity and Cancer in Human Using a Novel Electrical Capacitance Tomography Scanner
This study is testing a new scanner to see if it can help tell the difference between healthy, benign, and cancerous breast tissues in women getting routine breast checks.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Zedsen Limited Industry-sponsored |
| Locations | 1 site (London) |
| Trial ID | NCT06264934 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of the Z-scanner in measuring permittivity values to distinguish between healthy, benign, and malignant breast tissues. The study will involve 90 women attending routine breast assessments, divided into two parts: the first part will focus on the repeatability and reproducibility of the scanner's results, while the second part will assess its ability to differentiate between benign and cancerous lesions. By analyzing the permittivity of breast tissues, researchers hope to improve non-invasive cancer detection methods.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 and older who are attending a breast clinic for routine assessments.
Not a fit: Patients who have undergone recent biopsies, have implanted electronics, or are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to a more accurate and non-invasive method for detecting breast cancer.
How similar studies have performed: While there is ongoing research into permittivity for cancer detection, this specific approach using the Z-scanner is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Attending a symptomatic clinic or other appointment at a participating breast clinic site * Assigned female sex at time of birth * Aged 18 years or older at time of scan * Willing, able and mentally competent to read, understand, and provided informed consent in English Exclusion Criteria: * Participants who have undergone biopsy less than 14 days before the Z-scanner scan * Participants with implanted electronics * Participants with breast implants * Participants with nipple piercings (unless they are removed prior to the scan) * Participants who are lactating * Pregnant participants by verbal confirmation * Participants with pacemakers * Participants with open breast wound * Participants who had previous breast surgery (mastectomy, lumpectomy)
Where this trial is running
London
- Imperial College Healthcare NHS Trust — London, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Jessica Lin
- Email: jessica@zedsen.com
- Phone: +44 (0) 7873930941
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.